Liberate Bio

📍 Boston, United States🗓 Founded 2022👥 10 employees💰 Last funded Sep 2022
Biotechnology Research🌐 liberatebio.com
Website LinkedIn
Today, the biggest bottleneck in genetic medicine isn’t the power of mRNA, CRISPR, or gene therapy—it’s that we can’t get these medicines anywhere but the liver. Our RAPTOR™ platform is the first AI-driven system that makes extrahepatic genetic medicine scalable. Unlike the slow, inefficient trial-and-error process that dominates biotech, we directly test hundreds of novel lipid nanoparticles (LNPs) in non-human primates (NHPs) at 100 times lower cost, generating real-world, human-relevant data.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Liberate Bio?
Liberate Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Liberate Bio last raise funding?
The most recent investment in Liberate Bio recorded on gritt.io was in September 2022.
When was Liberate Bio founded?
Liberate Bio was founded in 2022.
What industry is Liberate Bio in?
Liberate Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Liberate Bio based?
Liberate Bio is headquartered in Boston, United States.